RadNet (RDNT) Stock Price, News & Analysis

Company Overview

RadNet, Inc. is an outpatient diagnostic imaging company that provides medical imaging services through a network of imaging centers and affiliated facilities. Its services support the diagnosis and monitoring of a wide range of medical conditions and are generally provided on an outpatient basis, outside of traditional hospital settings.

The company’s imaging offerings include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), mammography, ultrasound, X-ray and other diagnostic procedures. RadNet also provides women’s imaging, breast imaging and related radiology services, and has invested in digital health and artificial intelligence technologies intended to support image interpretation, clinical workflows and patient care.

RadNet serves patients and referring physicians primarily in the United States, with operations concentrated in regional markets including California and several states in the Northeast and Mid-Atlantic. The company was founded in 1981 and is headquartered in Los Angeles, California. Howard G. Berger serves as RadNet’s president and chief executive officer.

Key Stats

• Today's Range: $72.68 to $74.35
• 50-Day Range: $59.22 to $77.78
• 52-Week Range: $50.82 to $85.84
• Volume: 560,678 shs
• Average Volume: 750,352 shs
• Market Capitalization: $5.76 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $90.00
• Consensus Rating: Moderate Buy

RadNet Stock Analysis - MarketRank™

RadNet scored higher than 57% of companies evaluated by MarketBeat, and ranked 332nd out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

RadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 2 strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

RadNet has a consensus price target of $90.00, representing about 22.9% upside from its current price of $73.21.

Amount of Analyst Coverage

RadNet has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 77.55%

Earnings Growth

Earnings for RadNet are expected to grow by 77.55% in the coming year, from $0.49 to $0.87 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of RadNet is -271.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of RadNet is -271.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

RadNet has a P/B Ratio of 4.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

13.32% of the float of RadNet has been sold short.

Short Interest Ratio / Days to Cover

RadNet has a short interest ratio ("days to cover") of 19.47, which indicates bearish sentiment.

Change versus previous month

Short interest in RadNet has recently increased by 2.64%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

RadNet does not currently pay a dividend.

Dividend Growth

RadNet does not have a long track record of dividend growth.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: 0.33

News Sentiment

RadNet has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for RadNet this week, compared to 4 articles on an average week.

Search Interest

Only 2 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, RadNet insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.14% of the stock of RadNet is held by insiders.

Percentage Held by Institutions

77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 9/23/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:RDNT
• CIK: 790526
• Web: www.radnet.com
• Phone: (310) 478-7808
• Fax: 310-445-2980
• Employees: 11,264
• Year Founded: 1981

Price Target and Rating

• Average Price Target for RadNet: $90.00
• High Price Target: $95.00
• Low Price Target: $79.00
• Potential Upside/Downside: +22.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 149.41
• P/E Growth: N/A
• Net Income: -$18.65 million
• Net Margins: -0.93%
• Pretax Margin: 1.54%
• Return on Equity: 2.61%
• Return on Assets: 0.91%

Debt

• Debt-to-Equity Ratio: 0.94
• Current Ratio: 1.48
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $2.04 billion
• Price / Sales: 2.82
• Cash Flow: $3.19 per share
• Price / Cash Flow: 22.93
• Book Value: $17.58 per share
• Price / Book: 4.16

Miscellaneous

• Outstanding Shares: 78,700,000
• Free Float: 74,652,000
• Market Cap: $5.76 billion
• Optionable: Optionable
• Beta: 1.41